Entecavir: all 106 studies that test it
Page 1 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Viral Suppression With 0.5 mg and 1.0 mg Daily Doses of Entecavir in Decompensated HBV Cirrhosis of LiverRecruitingNCT07816094Phase 4
- Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis BNot yet recruitingNCT07345624Phase 4
- Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis BNot yet recruitingNCT07345611Phase 4
- Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV DonorsRecruitingNCT07189377Phase 4
- Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B CarriersRecruitingNCT06966232Phase 3
- Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis BRecruitingNCT03933384Phase 4
- A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical SettingCompletedNCT03083821Phase 1Results posted
- Extension Study of the Safety and Efficacy of Multi-dose Intravenous ARC-520 in Patients With Chronic Hepatitis B (HBV) InfectionTerminatedNCT02738008Phase 2Results posted
- A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant PhaseCompletedNCT02263079Phase 3Results posted
- A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) InfectionTerminatedNCT02065336Phase 2Results posted
- Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir TrialsCompletedNCT01438424Phase 2Results posted
- Lactic Acidosis During Entecavir(ETV)TreatmentTerminatedNCT01354652Phase 4Results posted
- A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus InfectionCompletedNCT01079806Phase 3Results posted
- Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous TreatmentCompletedNCT01063036Phase 3Results posted
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis BCompletedNCT00922207Phase 4Results posted
- Suboptimal Responders to Adefovir Switching to EntecavirCompletedNCT00718887Phase 4Results posted
- A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B InfectionTerminatedNCT00605384Phase 3Results posted
- A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-InfectionCompletedNCT00423891Phase 1/2Results posted
- Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant VirusCompletedNCT00410202Phase 3Results posted
- Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis BCompletedNCT00410072Phase 3Results posted
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus InfectionCompletedNCT00395018Phase 3Results posted
- A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B InfectionCompletedNCT00393484Phase 4Results posted
- Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT00371150Phase 4Results posted
- Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.CompletedNCT00298363Phase 2Results posted
- Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B InfectionCompletedNCT00096785Phase 3Results posted
- Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic DecompensationCompletedNCT00065507Phase 3Results posted
- Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir AmibufenamideCompletedNCT07295873Phase 1
- The Renal Safety of Tenofovir Alafenamide in HBV-related Acute-on-chronic Liver Failure: Real-World StudyCompletedNCT05453448Not applicable
- Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)Active, not recruitingNCT05453435Phase 2
- Antiviral Therapy for Patients With Chronic Hepatitis B InfectionStatus unknownNCT05382351Phase 2
- The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D InfectionCompletedNCT04638439Phase 1
- A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB SubjectsCompletedNCT04536337Phase 1
- A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With EntecavirCompletedNCT04365933Phase 2
- Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc)Status unknownNCT04199819Not applicable
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis bStatus unknownNCT04195074Not applicable
- Metformin as Add-on to the Standard Therapy in Patients With Chronic Hepatitis BCompletedNCT04182321Not applicable
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyStatus unknownNCT04157257Phase 2
- RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative ResectionActive, not recruitingNCT04032860Phase 4
- The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical TrialCompletedNCT03509688Not applicable
- Drug Drug Interaction Study for EYP001 With EntecavirCompletedNCT03469583Phase 1
- Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B PatientsStatus unknownNCT03332329Phase 4
- The Effect of Entecavir Consolidation on Post-TDF Treatment DurabilityStatus unknownNCT03308890Phase 4
- A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy SubjectsCompletedNCT03239353Phase 1
- Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy VolunteersTerminatedNCT03032536Phase 1
- Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and EntecavirStatus unknownNCT02945982Phase 4
- Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02945956Phase 4
- Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis PatientsActive, not recruitingNCT02849132Phase 4
- Prophylactic or Preemptive Entecavir in Patients With Colorectal Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777814Phase 2
- Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B CarriersStatus unknownNCT02777801Phase 2
- Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCCCompletedNCT02650271Phase 3
- An Exploratory Study of RGT Strategy on Optimal NUC-experienced PatientsStatus unknownNCT02560649Phase 4
- DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO)CompletedNCT02555943Phase 2/3
- Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With BaracludeStatus unknownNCT02523547Phase 4
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues TherapyCompletedNCT02505009Phase 4
- Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis BStatus unknownNCT02482272Phase 4
- Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02368288Phase 4
- Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a TreatmentStatus unknownNCT02365402Phase 4
- Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02241590Phase 4
- A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated CirrhosisStatus unknownNCT02238860Phase 4
- Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis BCompletedNCT01926288Phase 4
- A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to EntecavirCompletedNCT01918631Not applicable
- Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHLStatus unknownNCT01914744Phase 2
- Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis PatientsStatus unknownNCT01907230Phase 4
- Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis BStatus unknownNCT01906580Phase 4
- 3E Extension StudyStatus unknownNCT01834508Phase 4
- Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALTStatus unknownNCT01833611Phase 4
- Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01829685Phase 4
- Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based ImmunochemotherapyStatus unknownNCT01768195Phase 4
- Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With LymphomaStatus unknownNCT01765231Phase 4
- Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous TreatmentStatus unknownNCT01724723Phase 4
- Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to EntecavirCompletedNCT01711567Phase 4
- Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαTerminatedNCT01694264Phase 3
- Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis BCompletedNCT01639066Phase 4
- Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute ExacerbationTerminatedNCT01627223Phase 4
- Antiviral Efficacy of Switching to ETV Plus TDFStatus unknownNCT01597934Phase 4
- Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionStatus unknownNCT01594905Phase 4
- Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus LamivudineCompletedNCT01580202Phase 3
- Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01341743Phase 4
- Induction of Fibrosis Regression on Patients With Chronic Hepatitis B InfectionTerminatedNCT01341106Phase 4
- The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver FailureCompletedNCT01254994Phase 2
- A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.WithdrawnNCT01179594Phase 4
- Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT01148576Phase 4
- Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With EntecavirCompletedNCT01046799Phase 3
- Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine TherapyCompletedNCT01037166Phase 2
- An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B InfectionCompletedNCT01037062Phase 2
- A Phase II Dose Response Study in Japan in Chronic Hepatitis BCompletedNCT01022801Phase 2
- A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B InfectionCompletedNCT01020565Phase 2
- Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral LoadCompletedNCT01013272Not applicable
- Simvastatin for the Treatment of Chronic Hepatitis BCompletedNCT00994773Phase 1
- Entecavir Plus Adefovir in Lamivudine-Resistant PatientsWithdrawnNCT00986778Phase 4
- Continue Entecavir Rollover From ChinaCompletedNCT00975091Phase 3
- Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma PatientsStatus unknownNCT00931229Not applicable
- Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis BCompletedNCT00926757Phase 4
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis BStatus unknownNCT00921180Phase 4
- Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver CancerCompletedNCT00824707Not applicable
- Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease PatientsStatus unknownNCT00823550Phase 4
- Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related CirrhosisStatus unknownNCT00663182Phase 4
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNACompletedNCT00637663Phase 4
- Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNACompletedNCT00625560Phase 4
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNACompletedNCT00625339Phase 4